Response to subdermal implantation of textured microimplants in humans.
In lieu of the problems involved with the use of foreign substances such as ivory, paraffin, liquid silicone, and collagen, a new subcutaneous injectable device has been developed. This material--Bioplastique--has been developed in an attempt to overcome the shortcomings of previous augmentation materials, most notably absorption, migration, and immunologic rejection. This article presents a longitudinal study of the use of this new microimplant.